You can purchase shares of Immunic (NASDAQ:IMUX) through any online brokerage.

View our list of the best stock brokerages

Other companies in Immunic’s space includes: Macrogenics Inc (NASDAQ:MGNX), Innate Pharma SA (NASDAQ:IPHA), Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL), Connect Biopharma Holdings Ltd (NASDAQ:CNTB) and Fate Therapeutics Inc (NASDAQ:FATE).

Immunic has a consensus price target of $9.33.

The stock price for Immunic (NASDAQ: IMUX) is $1.2399 last updated March 9, 2026 at 7:32 PM EDT.

There are no upcoming dividends for Immunic.

Immunic does not have any upcoming earnings scheduled.

There is no upcoming split for Immunic.

Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.